A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies

Japanese Journal of Clinical Oncology

Volumn 29, Issue 6, 1999, Pages 299-302

  Ito, Kimihiko ^a   Adachi, Susumu ^b   Itani, Yoshio ^a   Koyama, Masayasu ^a   Hori, Kensuke ^a   Chin, Rika ^a   Shintani, Masahumi ^c   Beppu, Kenichi ^c   Kawai, Seigo ^c   Saito, Kensuke ^d  

^a Hyogo Prefectural Nishinomiya Hospital   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c Nara Prefectural Mimuro Hospital   (Japan)

^d Saiseikai Tondabayashi Hospital   (Japan)

Author keywords

Combination chemotherapy; Cyclophosphamide; Nedaplatin; Ovarian cancer; Uterine cervical cancer

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; NEDAPLATIN; PLATINUM COMPLEX;

ADULT; ARTICLE; BONE MARROW; CLINICAL TRIAL; DISEASE COURSE; DRUG ADMINISTRATION; DRUG EFFECT; ERYTHROCYTE COUNT; FEASIBILITY STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MIDDLE AGED; NEUTROPHIL; OVARY TUMOR; REMISSION; SURVIVAL RATE; THROMBOCYTE COUNT; UTERINE CERVIX TUMOR;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTE COUNT; FEASIBILITY STUDIES; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LEUKOCYTE COUNT; MIDDLE AGED; NEUTROPHILS; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PLATELET COUNT; REMISSION INDUCTION; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0033142252     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.6.299     Document Type: Article

References (23)

1. Canetta R, Rosencweig M, Carter SK. Carboplatin: the clinical spectrum to data. Cancer Treat Rev 1985;12:125-36.
2. Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil and flonic acid in metastatic colorectal cancer. Lancet 1997;350:681-6.
3. Shiratori O, Kanai H, Uchida N, Takeda Y, Totani T, Sato K. Antitumor activity and toxicity of 254-S, a platinum complex, in rodents. In: Ishigami J, editor. Recent Advances in Chemotherapy. Tokyo: University of Tokyo Press 1985;635-6.
4. Hirabayashi Y, Okada E. Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer. Cancer 1992;71:2769-75.
5. Adachi S, Ogasawara T, Yamasaki N, Shibahara H, Tsuji Y, Takemura T, et al. A pilot study of nedaplatin and etoposide for recurrent gynecological malignancies. Oncol Rep 1998;8:881-4.
6. Advanced Ovarian Cancer Trialists Group. Chemotherapy in advanced ovarian cancer: an overview of randomized clinical trials. Br Med J 1992;303:884-93.
7. Tan LT, Jones B, Green JA, Kingston RE, Clark PI. Treatment of carcinomas of the uterine cervix which remain bulky after initial external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy. Br J Radiol 1996;69:165-72.
8. Ota K, Wakui A, Majima H, Niitani H, Inuyama Y, Ogawa M, et al. Phase I study of a new platinum complex 254-S, cis-diammine(glycolato)platinum(II). Gan To Kagaku Ryoho 1992;19:855-61 (in Japanese).
9. Yonei T. Quantitative analysis of in vitro combination effects of platinum analogues and etoposide against human lung cancer cells. Haigan 1991;31:221-7 (in Japanese).
10. Furuse K, Fukuoka M, Asamoto H, Niitani H, Kimura I, Sakuma A, et al. A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC). Gan To Kagaku Ryoho 1992;19:1019-26 (in Japanese).
11. Kato T, Nishimura H, Yamabe T, Terashima Y, Kasamatsu T, Hirabayashi K, et al. Phase II study of carboplatin for ovarian cancer. Gan To Kagaku Ryoho 1988;15:2291-6 (in Japanese).
12. Kato T, Nishimura H, Yakushiji M, Noda K, Terashima Y, Takeuchi S, et al. Phase II study of 254-S (cis-diammineglycolatoplatinum) for gynecological cancer. Gan To Kagaku Ryoho 1992;19:695-701 (in Japanese).
13. Noda K, Takeuchi S, Kurihara S, Sugawa T, Kato T, Ikeda M, et al. Phase II study of cisplatin for cervical and endometrial carcinomas. Gan To Kanaku Ryoho 1987;14:1129-35 (in Japanese).
14. Noda K, Kato T, Ikeda M, Akiya K, Yajima A, Ueda G, et al. Phase II study of carboplatin in cervical carcinoma. Gan To Kagaku Ryoho 1988;15:3067-72 (in Japanese).
15. Williams CJ, Mead GM, Macbeth FR, Thompson J, Whitehouse JM, MacDonald H, et al. Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial. J Clin Oncol 1985;3:1455-62.
16. Gruppo Interegionale Cooperativo Oncologico Ginecologia. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Lancet 1987;2:353-9.
17. Omura GA, Bundy BN, Berek JS, Curry S, Delgado G, Mortel R. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 1989;7:457-65.
18. Alberts DS, Green S, Hannigan EV, O'Toole R, Stock-Novack D, Anderson P, et al. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of phase III randomized trial in stage III and IV ovarian cancer. J Clin Oncol 1992;10:706-17.
19. Jakobsen A, Bertelsen K, Andersen JE, Havsteen H, Jakobsen P, Moeller KA, et al. Dose-effective study of carboplatin in ovarian cancer; a Danish Ovarian Cancer Group study. J Clin Oncol 1997;15:193-8.
20. Gore M, Mainwaring P, A'Hern R, MacFarlane V, Slevin M, Harper P, et al. for the London Gynecological Oncology Group. Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. J Clin Oncol 1998;16:2426-34.
21. Kaye SB, Paul J, Cassidy J, Lewis CR, Duncan ID, Gordon HK, et al. for the Scottish Gynecology Cancer Trials Group. Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer.J Clin Oncol 1996;14:2113-9.
22. MacGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
23. Pignata S, De Vivo R, Ricchi R, Perrone F, Botti G, Monfardini S. Chemotherapy in squamous cell carcinoma of the cervix uteri: present role and perspectives. Cancer Treat Rev 1998;24:27-34.